JP2024546939A5 - - Google Patents

Info

Publication number
JP2024546939A5
JP2024546939A5 JP2024535882A JP2024535882A JP2024546939A5 JP 2024546939 A5 JP2024546939 A5 JP 2024546939A5 JP 2024535882 A JP2024535882 A JP 2024535882A JP 2024535882 A JP2024535882 A JP 2024535882A JP 2024546939 A5 JP2024546939 A5 JP 2024546939A5
Authority
JP
Japan
Prior art keywords
cancers
antibody
indicated
antigen
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535882A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546939A (ja
Filing date
Publication date
Priority claimed from CN202111552957.3A external-priority patent/CN116265486A/zh
Application filed filed Critical
Publication of JP2024546939A publication Critical patent/JP2024546939A/ja
Publication of JP2024546939A5 publication Critical patent/JP2024546939A5/ja
Pending legal-status Critical Current

Links

JP2024535882A 2021-12-17 2022-12-16 ヒトｃｄ７３と結合する抗体、その製造方法と使用 Pending JP2024546939A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202111552957.3A CN116265486A (zh) 2021-12-17 2021-12-17 结合人cd73的抗体、其制备方法和用途
CN202111552957.3 2021-12-17
PCT/CN2022/139741 WO2023109962A1 (zh) 2021-12-17 2022-12-16 结合人cd73的抗体、其制备方法和用途

Publications (2)

Publication Number Publication Date
JP2024546939A JP2024546939A (ja) 2024-12-26
JP2024546939A5 true JP2024546939A5 (cg-RX-API-DMAC7.html) 2025-07-07

Family

ID=86743764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535882A Pending JP2024546939A (ja) 2021-12-17 2022-12-16 ヒトｃｄ７３と結合する抗体、その製造方法と使用

Country Status (4)

Country Link
US (1) US20250066499A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024546939A (cg-RX-API-DMAC7.html)
CN (1) CN116265486A (cg-RX-API-DMAC7.html)
WO (1) WO2023109962A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119744177A (zh) * 2023-07-24 2025-04-01 石药集团巨石生物制药有限公司 重组人源化抗cd73单克隆抗体的药物组合物
CN119751685A (zh) * 2024-10-29 2025-04-04 浙江大学 高酶活抑制能力的差异化抗cd73单克隆抗体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11530273B2 (en) * 2017-05-23 2022-12-20 Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Anti-CD73 monoclonal antibody, encoding nucleic acids and method for producing
CN110240654A (zh) * 2018-03-07 2019-09-17 复旦大学 结合cd73的抗体-药物偶联物
EP3762030A4 (en) * 2018-03-09 2022-01-05 Phanes Therapeutics, Inc. ANTI-CD73 ANTIBODIES AND USES THEREOF
US20220220218A1 (en) * 2018-11-12 2022-07-14 Jiangsu Hengrui Medicine Co., Ltd. Anti-cd73 antibody, antigen-binding fragment thereof and application thereof
CN111499747B (zh) * 2019-01-11 2022-03-18 康诺亚生物医药科技（成都）有限公司 一种抗cd73单克隆抗体及其应用
CN117946274B (zh) * 2019-06-19 2026-02-17 杭州博之锐生物制药有限公司 抗cd73抗体及其应用

Similar Documents

Publication Publication Date Title
CN106519034B (zh) 抗pd-1抗体及其用途
RU2628094C2 (ru) Антитела, способные специфически связываться с her2
JP2021526022A5 (cg-RX-API-DMAC7.html)
RU2007133108A (ru) АНТИТЕЛА, СВЯЗЫВАЮЩИЕСЯ С EphA2, И МЕТОДЫ ИХ ИСПОЛЬЗОВАНИЯ
US12565534B2 (en) Nano-antibody targeting CAIX antigen and application thereof
CN108164600B (zh) 一种抗gpc3抗体及其制备方法和用途
WO2024175093A1 (en) Antibodies, antigen-binding fragments and methods of use
JP2024546939A5 (cg-RX-API-DMAC7.html)
CN111819200A (zh) 抗c-met抗体
TWI906795B (zh) 特異性結合Ｃｌａｕｄｉｎ １８.２的抗體及其製法和應用
CN118047871A (zh) 一种靶向FRα的抗体或其抗原结合片段及其应用
JP2025524306A (ja) Ｉｔｇａ２を標的とする抗体及びそれを含む抗体薬物複合体
CN109879966B (zh) 基于鼠源cd19抗体的人源化设计及表达验证
JP2024546939A (ja) ヒトｃｄ７３と結合する抗体、その製造方法と使用
AU2024302839A1 (en) Anti-gpc3 antibody or antigen-binding fragment and use thereof
IL311153A (en) Bispecific antibody and its use
WO2024131846A1 (en) Antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
WO2025146161A1 (en) Antibody, antigen-binding fragment and medical use thereof
TWI918239B (zh) Ｇｄｆ１５中和抗體及其用途
WO2024131835A1 (en) Ligand-cytotoxicity drug conjugates and pharmaceutical uses thereof
NZ783695B2 (en) Binding molecule specific for cd73 and use of binding molecule
WO2026026985A1 (zh) 一种结合steap1的抗体或其抗原结合部分及其应用
KR20240099470A (ko) 항-cldn18.2 단일클론 항체 및 이의 응용
NZ783695A (en) Binding molecule specific for cd73 and use of binding molecule
WO2026026986A1 (zh) 结合steap1的抗体或其抗原结合部分及其应用